Stock Taper
SCREENER COMPARE ANY 2 STOCKS
NBP
NOVABRIDGE BIOSCIENCES
NASDAQ
$2.00
▲ UP 4.71% (0.09)

KEY STATISTICS

Market Cap$230.53 M
52w High$6.79
52w Low$1.46
Dividend Yield—
Frequency—
P/E-5.13
Volume443.08K
Shares Out.115.27M

COMPANY

LEADERSHIP

Srishti Gupta
CHIEF EXECUTIVE
Srishti Gupta

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 17, 2020
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
30

PRICE TARGET

Target High$9.00
Target Low$9.00
Target Median$9.00
Target Consensus$9.00

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.—
NOV
12
THU

PRICE

$2.00 ▲ UP 4.71% (+$0.09)
$1.92$1.96$2.009:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM2.00

About NovaBridge Biosciences

https://www.novabridge.com ↗

NovaBridge Biosciences, founded in 2014 and based in Maryland, develops immuno-oncology agents like givastomig, uliledlimab, and ragistomig, with multiple clinical trials and collaborations with major partners.

INDUSTRY

Biotechnology

A PRODUCT NOVABRIDGE BIOSCIENCES IS KNOWN FOR

Givastomig
Givastomig

Givastomig, a bispecific antibody by NovaBridge Biosciences, targets gastric and gastrointestinal cancers and has recently entered a global Phase 2 trial.

COMPETITORS

COMPETITOR
AGEN COMPARE
BMY COMPARE
LEGN COMPARE
ZYME COMPARE

Revenue by Products

IconPRODUCTQ3-2020Q4-2020Q2-2022Q4-2022
Supply Of Investigational Products— — $28.1M —
Licensing and Collaboration— — $23.76M —
Grant$10M $0 ▼— $18.9M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
5
LISTED HERE
3
RANKED BY POSITION SIZE
SPEM
0.00% · 297.9K
SBIO
0.11% · 135.9K
BIB
0.01% · 3.8K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF COMMERCIAL OFFICER
Hagler Mark Arnold
Purchase · 949.0K shares
2026-07-08
★
OFFICER: GENERAL COUNSEL
Lin Liwei Lorraine
Purchase · 254.8K shares
2026-07-08
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Gupta Srishti
Purchase · 3.0M shares
2026-07-06
★
Gupta Srishti
— · —
2026-07-01

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
3 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY BTIG BUY Needham BUY

SECTORS PEERS

PEERPRICE
LBRX$47.62COMPARE
DRTS$14.92COMPARE
DSGN$14.99COMPARE
ANNX$5.07COMPARE
AURA$7.80COMPARE
ALT$3.11COMPARE
RCKT$3.51COMPARE
DMAC$6.52COMPARE